A novel QSAR model for predicting the inhibition of CXCR3 receptor by 4-N-aryl-[1,4] diazepane ureas.

A linear quantitative structure-activity relationship (QSAR) model is presented for modeling and predicting the inhibition of CXCR3 receptor. The model was produced by using the multiple linear regression (MLR) technique on a database that consists of 32 recently discovered 4-N-aryl-[1,4] diazepane ureas. The key conclusion of this study is that 3k, ChiInf8, ChiInf0, AtomCompTotal and ClogP affect significantly the inhibition of CXCR3 receptor by diazepane ureas. The selected physicochemical descriptors serve as a first guideline for the design of novel and potent antagonists of CXCR3.

[1]  P. Ghosh,et al.  On an aspect of calculated molecular descriptors in QSAR studies of quinolone antibacterials , 2006, Molecular Diversity.

[2]  C W Yap,et al.  Regression methods for developing QSAR and QSPR models to predict compounds of specific pharmacodynamic, pharmacokinetic and toxicological properties. , 2007, Mini reviews in medicinal chemistry.

[3]  Simon A. Jones,et al.  Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes , 1996, The Journal of experimental medicine.

[4]  Helen L Birch,et al.  Development of CXCR3 antagonists. Part 3: Tropenyl and homotropenyl-piperidine urea derivatives. , 2008, Bioorganic & medicinal chemistry letters.

[5]  M. Jalali-Heravi,et al.  QSAR study of heparanase inhibitors activity using artificial neural networks and Levenberg-Marquardt algorithm. , 2008, European journal of medicinal chemistry.

[6]  D. Steinberg,et al.  Technometrics , 2008 .

[7]  Maria L Webb,et al.  Identification and initial evaluation of 4-N-aryl-[1,4]diazepane ureas as potent CXCR3 antagonists. , 2006, Bioorganic & medicinal chemistry letters.

[8]  A. Tropsha,et al.  Beware of q2! , 2002, Journal of molecular graphics & modelling.

[9]  Pramod C. Nair,et al.  Quantitative structure activity relationship studies on thiourea analogues as influenza virus neuraminidase inhibitors. , 2008, European journal of medicinal chemistry.

[10]  Desire L. Massart,et al.  Artificial neural networks in classification of NIR spectral data: Design of the training set , 1996 .

[11]  A. Khlebnikov,et al.  Quantitative structure-activity relationships for small non-peptide antagonists of CXCR2: indirect 3D approach using the frontal polygon method. , 2006, Bioorganic & medicinal chemistry.

[12]  Haralambos Sarimveis,et al.  Identification of a series of novel derivatives as potent HCV inhibitors by a ligand-based virtual screening optimized procedure. , 2007, Bioorganic & medicinal chemistry.

[13]  Haralambos Sarimveis,et al.  A novel QSAR model for predicting induction of apoptosis by 4-aryl-4H-chromenes. , 2006, Bioorganic & medicinal chemistry.

[14]  L. A. Stone,et al.  Computer Aided Design of Experiments , 1969 .

[15]  Knut Baumann,et al.  Cross-validation as the objective function for variable-selection techniques , 2003 .

[16]  Yun Tang,et al.  Structure-based 3D-QSAR studies on heteroarylpiperazine derivatives as 5-HT3 receptor antagonists. , 2007, European journal of medicinal chemistry.

[17]  Haralambos Sarimveis,et al.  Investigation of substituent effect of 1-(3,3-diphenylpropyl)-piperidinyl phenylacetamides on CCR5 binding affinity using QSAR and virtual screening techniques , 2006, J. Comput. Aided Mol. Des..

[18]  Asit K Chakraborti,et al.  3D-QSAR studies of indole derivatives as phosphodiesterase IV inhibitors. , 2003, European journal of medicinal chemistry.

[19]  S. Deswal,et al.  A novel range based QSAR study of human neuropeptide Y (NPY) Y5 receptor inhibitors. , 2007, European journal of medicinal chemistry.

[20]  Anahita Kyani,et al.  Application of genetic algorithm-kernel partial least square as a novel nonlinear feature selection method: activity of carbonic anhydrase II inhibitors. , 2007, European journal of medicinal chemistry.

[21]  Isabelle Guyon,et al.  An Introduction to Variable and Feature Selection , 2003, J. Mach. Learn. Res..

[22]  M. Forina,et al.  Affinity prediction on A1 adenosine receptor agonists: the chemometric approach. , 2006, Bioorganic & medicinal chemistry.

[23]  Roberto Todeschini,et al.  Handbook of Molecular Descriptors , 2002 .

[24]  A. Balaban,et al.  Topological Indices and Related Descriptors in QSAR and QSPR , 2003 .

[25]  Haralambos Sarimveis,et al.  Optimization of biaryl piperidine and 4-amino-2-biarylurea MCH1 receptor antagonists using QSAR modeling, classification techniques and virtual screening , 2007, J. Comput. Aided Mol. Des..

[26]  Haralambos Sarimveis,et al.  A Novel QSAR Model for Evaluating and Predicting the Inhibition Activity of Dipeptidyl Aspartyl Fluoromethylketones , 2006 .

[27]  R. Todeschini,et al.  Detecting bad regression models: multicriteria fitness functions in regression analysis , 2004 .

[28]  H. J. Mclaughlin,et al.  Learn , 2002 .

[29]  Paola Gramatica,et al.  The Importance of Being Earnest: Validation is the Absolute Essential for Successful Application and Interpretation of QSPR Models , 2003 .

[30]  G. Oliva,et al.  Virtual screening and its integration with modern drug design technologies. , 2008, Current medicinal chemistry.

[31]  J. Matysiak.  Evaluation of electronic, lipophilic and membrane affinity effects on antiproliferative activity of 5-substituted-2-(2,4-dihydroxyphenyl)-1,3,4-thiadiazoles against various human cancer cells. , 2007, European journal of medicinal chemistry.

[32]  Haralambos Sarimveis,et al.  A Novel RBF Neural Network Training Methodology to Predict Toxicity to Vibrio Fischeri , 2006, Molecular Diversity.

[33]  Kyle V. Camarda,et al.  Optimization in polymer design using connectivity indices , 1999 .

[34]  Judith C. Madden,et al.  Consensus QSAR Models: Do the Benefits Outweigh the Complexity? , 2007, J. Chem. Inf. Model..

[35]  P. Bharatam,et al.  3D-QSAR studies of substituted 1-(3, 3-diphenylpropyl)-piperidinyl amides and ureas as CCR5 receptor antagonists , 2007, Journal of molecular modeling.

[36]  G. Melagraki,et al.  QSAR study on para-substituted aromatic sulfonamides as carbonic anhydrase II inhibitors using topological information indices. , 2006, Bioorganic & medicinal chemistry.

[37]  Herman van Vlijmen,et al.  Recent advances in chemoinformatics. , 2007, Journal of chemical information and modeling.

[38]  Raimund Mannhold,et al.  Substructure versus Whole‐molecule Approaches for Calculating Log P , 2003 .

[39]  A. Andricopulo,et al.  2D Quantitative structure-activity relationship studies on a series of cholesteryl ester transfer protein inhibitors. , 2007, Bioorganic & medicinal chemistry.

[40]  Xiaoyun Zhang,et al.  Quantitative structure-activity relationship studies of a series of non-benzodiazepine structural ligands binding to benzodiazepine receptor. , 2008, European journal of medicinal chemistry.

[41]  Haralambos Sarimveis,et al.  A novel simple QSAR model for the prediction of anti-HIV activity using multiple linear regression analysis , 2006, Molecular Diversity.

[42]  A. Talevi,et al.  Application of descriptors based on Lipinski's rules in the QSPR study of aqueous solubilities. , 2007, Bioorganic & medicinal chemistry.

[43]  Ingo Muegge,et al.  Advances in virtual screening , 2006, Drug Discovery Today: Technologies.

[44]  S. Papson,et al.  “Model” , 1981 .

[45]  Zixuan Wang,et al.  A simple, Automated Quasi‐4D‐QSAR, Quasi‐multi Way PLS Approach to Develop Highly Predictive QSAR Models for Highly Flexible CXCR4 Inhibitor Cyclic Pentapeptide Ligands Using Scripted Common Molecular Modeling Tools , 2005 .

[46]  Elena Konstantinova,et al.  On some applications of information indices in chemical graph theory , 2005, Electron. Notes Discret. Math..

[47]  D. Owen,et al.  Identification and structure-activity relationships of 1-aryl-3-piperidin-4-yl-urea derivatives as CXCR3 receptor antagonists. , 2007, Bioorganic & medicinal chemistry letters.